NVAX FY 2007 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena

NVAXNovavax, Inc.

$2B

FY 2007 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-67.7% YoY

Gross Profit

$1M85.4% margin

Operating Income

-$30M-2000.7% margin

Net Income

-$35M-2297.8% margin

EPS (Diluted)

$-11.38

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$29M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$91M

Total Liabilities

$28M

Stockholders' Equity

$63M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$5M	-67.7%
Gross Profit	$1M	-$2M	+172.2%
Operating Income	-$30M	-$25M	-23.0%
Net Income	-$35M	-$23M	-50.7%